BridgeMD
New treatment option for Juvenile Idiopathic Arthritis
Official title Pain in Juvenile Arthritis
ClinicalTrials.gov ID: NCT07217782
What this study is testing
- What it's testing
- Juvenile idiopathic arthritis (JIA) is the most common rheumatologic disease in children. The main symptoms of JIA, which are often the primary focus of treatment, include joint swelling, stiffness, and tenderness.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 9 to 17. Healthy volunteers may be eligible.
You may be able to join if
- Age between 9-17
- Males and females
- English speakers
- Able to complete surveys and understand study instructions
- Juvenile arthritis group: diagnosed or suspected of juvenile arthritis
You likely can't join if
- Pregnancy or breastfeeding
- (Control Group) Diagnosed with a chronic pain condition
- (Control Group) Diagnosed with psychiatric condition including ADHD, anxiety, depression, etc.
See the full eligibility criteria
- Age between 9-17
- Males and females
- English speakers
- Able to complete surveys and understand study instructions
- Juvenile arthritis group: diagnosed or suspected of juvenile arthritis
- Control group: healthy
- Pregnancy or breastfeeding
- (Control Group) Diagnosed with a chronic pain condition
- (Control Group) Diagnosed with psychiatric condition including ADHD, anxiety, depression, etc.
The study team makes the final eligibility decision.
Where it's taking place
- St Louis, Missouri, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 9 years to 17 years. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include St Louis, Missouri, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.